Interested in Wholesale?
Contact Us Now
Be The First To Know About Wholesale, Exclusive Sales & More
BIENOX 100U
Bienox 100U — BNC Korea’s vacuum-dried Clostridium botulinum toxin type A. . Rapid 1–2 day onset, minimal excipients. Note: vacuum-drying produces a thin film at vial bottom — vial may appear empty (this is normal). For licensed healthcare professionals only.
$32.50
Quantity discounts
| Quantity | Discount | Price |
|---|---|---|
| 5-9 | 3% | $31.53 |
| 10-19 | 5% | $30.88 |
| 20-Unlimited | 8% | $29.90 |
Bienox 100U — BNC Korea Vacuum-Dried Botulinum Toxin
What it is
Bienox 100U is a Korean botulinum toxin type A injection manufactured by BNC Korea using vacuum-drying production technology. Each vial contains 100 units of purified Clostridium botulinum toxin type A. Unlike conventional freeze-drying which requires substantial bulk excipients to maintain powder structure, vacuum-drying dries the toxin under reduced pressure with minimal additives — producing a thin, almost invisible film at the vial bottom rather than a visible powder cake.
What makes it distinctive
Bienox’s defining feature is vacuum-drying technology — shared with only a few products on the global market (most prominently Daewoong’s Nabota). Compared to freeze-dried products, vacuum-drying preserves higher molecular integrity, requires fewer stabilizing excipients, and creates weaker negative pressure inside the vial — reducing protein denaturation during reconstitution. The trade-off is unfamiliar visual appearance: vials genuinely look empty to clinicians used to freeze-dried powder cakes. Rapid 1–2 day onset is supported by BNC clinical literature.
How vacuum-drying differs from freeze-drying
Freeze-drying (conventional lyophilization) sublimates frozen water under reduced pressure, requiring bulk excipients to maintain powder structure during freezing — resulting in a visible white cake at the vial bottom. Vacuum-drying skips the freezing step entirely: the toxin solution is dried under reduced pressure with minimal excipients, leaving an ultra-thin film of active ingredient bonded to the vial surface. Vacuum-drying preserves higher molecular weight integrity (less risk of ice-crystal damage to the toxin protein), requires fewer additives, and creates lower negative pressure inside the sealed vial. The visual cost is that the vial appears empty — but the active material is present and reconstitutes normally with saline.
Approved & off-label indications
Glabellar lines (frown lines)
Forehead lines
Crow’s feet (lateral canthal lines)
Masseter hypertrophy (jaw slimming / square jaw correction)
Salivary gland reduction
Chin wrinkles and perioral correction
Neck wrinkles
Mouth corner correction
Technical specifications
Detail for clinical, regulatory, and shipping reference.
| Active Ingredient | Clostridium botulinum toxin type A |
| Strain | Clostridium botulinum type A |
| Molecular Complex | 900 kDa |
| Units per vial | 100 units |
| Form | Vacuum-dried powder (thin film at vial bottom) |
| Excipients | Minimal (vacuum-drying requires fewer stabilizers) |
| Manufacturer | BNC Korea |
| Origin | South Korea |
| Approvals | Manufactured by BNC Korea in Korea · facility |
| Onset / Duration | 1–2 days onset (rapid) · approximately 4 months duration |
| Reconstitution | Sterile preservative-free 0.9% saline |
| Storage | Store at 2–8 °C, protect from light, do not freeze. |
| Reconstituted shelf life | 24 hours at 2–8 °C |
| Shelf life (unopened) | 36 months from manufacture |
| Intended use | Licensed medical professionals only |
Frequently Asked Questions
Why does the Bienox vial look empty?
Bienox uses vacuum-drying technology, which produces an ultra-thin film of active ingredient at the vial bottom rather than a visible powder cake. The vial really does look empty — this is the normal appearance of vacuum-dried botulinum toxin, not a packaging error or fake product. Hold the vial up to bright light at an angle to see the faint translucent film. When you add saline for reconstitution, the film dissolves and the product behaves identically to any other reconstituted botulinum toxin.
How is vacuum-drying different from freeze-drying?
Freeze-drying freezes the toxin solution then sublimates the water under vacuum — requiring substantial excipients to maintain powder structure, resulting in a visible white cake. Vacuum-drying skips the freezing step and dries the solution under reduced pressure with minimal excipients — preserving molecular integrity without the ice-crystal damage risk of freezing. The result is a thin invisible film, fewer additives in the final product, and reduced negative pressure inside the vial (which lowers protein denaturation during reconstitution).
How long does Bienox take to show results?
Onset is rapid at 1–2 days per BNC clinical literature — slightly faster than typical freeze-dried Korean toxins (3–5 days). Peak effect at approximately 7–14 days. Duration approximately 4 months in standard cosmetic indications, varying by injection site, dose, and individual patient metabolism.
What approvals does Bienox carry?
Bienox is Vacuum-dried, Jeuveau
Nabota 100U
Daewoong’s HI-PURE™ vacuum-dried formulation — US as Jeuveau.
Daewoong · Vacuum-dried 200U
Nabota 200U
Same Daewoong vacuum-dried HI-PURE™ at 200-unit pack — also as Jeuveau.
Hugel · K(MFDS 3-48905) + Letybo
Botulax 100U
Korea’s #1 botulinum brand — Hugel at high-purity, US as Letybo.
Pharma Research Bio · 100U Korean
ReNTOX 100U
Pharma Research Bio’s HSA-stabilized formulation with standard 3–4 month duration.
View product →
Browse all botulinum toxin products at MJS Medicals.
Safety
This product-specific: Bienox 100U uses vacuum-drying technology — the empty-looking vial is normal and does not indicate a fake product. Bienox 100U carries the same class-wide botulinum toxin warnings as all Type A products including potential distant toxin spread, neuromuscular junction disorder contraindications, and pregnancy/lactation contraindication. Always aspirate before injection; maintain emergency airway management equipment.
Botulinum toxin Type A is a prescription medical product for licensed healthcare professionals only. Contraindicated in neuromuscular junction disorders (myasthenia gravis, Lambert-Eaton, ALS); known hypersensitivity to botulinum toxin or excipients; pregnancy / breastfeeding; active local infection; concurrent aminoglycoside / anticholinesterase / curare-like drugs. Class-wide warning: rare distant toxin spread possible (symptoms hours-to-weeks post-injection). Maintain emergency airway management equipment and epinephrine.
Last reviewed: May 2026 · Source verification: Manufacturer official documentation · Multi-distributor cross-check
Related Products
Interested in Wholesale?
Contact Us Now
Be The First To Know About Wholesale, Exclusive Sales & More
Reviews
Clear filtersThere are no reviews yet.